HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $48,717,165 | -47.9% | 473,672 | -42.5% | 0.27% | -52.7% |
| Q4 2022 | $93,424,000 | +63.5% | 823,124 | -10.8% | 0.57% | +53.6% |
| Q3 2022 | $57,124,000 | -46.2% | 923,006 | -30.7% | 0.37% | -44.0% |
| Q2 2022 | $106,227,000 | -23.1% | 1,331,837 | +1.5% | 0.67% | -5.8% |
| Q1 2022 | $138,055,000 | -10.3% | 1,312,194 | -7.7% | 0.71% | +4.7% |
| Q4 2021 | $153,871,000 | -7.4% | 1,421,315 | -6.3% | 0.68% | -10.0% |
| Q3 2021 | $166,138,000 | -3.7% | 1,516,696 | -17.7% | 0.75% | +1.2% |
| Q2 2021 | $172,548,000 | -21.5% | 1,842,683 | -24.1% | 0.74% | -23.8% |
| Q1 2021 | $219,672,000 | +30.0% | 2,427,320 | +8.4% | 0.97% | +2.0% |
| Q4 2020 | $169,040,000 | -26.1% | 2,240,079 | -23.5% | 0.95% | -19.0% |
| Q3 2020 | $228,764,000 | +90.3% | 2,926,871 | +34.6% | 1.18% | +72.5% |
| Q2 2020 | $120,193,000 | +116.9% | 2,174,269 | +16.2% | 0.68% | +98.0% |
| Q1 2020 | $55,406,000 | -18.9% | 1,870,561 | -0.9% | 0.34% | +5.2% |
| Q4 2019 | $68,320,000 | +0.2% | 1,887,316 | -24.7% | 0.33% | -6.8% |
| Q3 2019 | $68,216,000 | – | 2,505,202 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |